Distribution of events of positive selection and population differentiation in a metabolic pathway: the case of asparagine N-glycosylation

Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway...

Full description

Saved in:
Bibliographic Details
Published inBMC evolutionary biology Vol. 12; no. 1; p. 98
Main Authors Dall’Olio, Giovanni Marco, Laayouni, Hafid, Luisi, Pierre, Sikora, Martin, Montanucci, Ludovica, Bertranpetit, Jaume
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 25.06.2012
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1. These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
AbstractList Doc number: 98 Abstract Background: Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Results: Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1 . Conclusions: These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
Background: Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment andinnate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Results:Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection arefrequent on genes that are known to be at bifurcation points, and that are identified as beingin key position by a network-level analysis such as MGAT3 and GCS1.Conclusions: These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
Abstract Background Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Results Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1. Conclusions These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1. These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints.BACKGROUNDAsparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints.Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1.RESULTSOur results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1.These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.CONCLUSIONSThese findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
BACKGROUND: Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. RESULTS: Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1. CONCLUSIONS: These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1. These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway.
Background Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be subdivided into two parts: an upstream sub-pathway required for achieving proper folding for most of the proteins synthesized in the secretory pathway, and a downstream sub-pathway required to give variability to trans-membrane proteins, and involved in adaptation to the environment and innate immunity. Here we analyze the nucleotide variability of the genes of this pathway in human populations, identifying which genes show greater population differentiation and which genes show signatures of recent positive selection. We also compare how these signals are distributed between the upstream and the downstream parts of the pathway, with the aim of exploring how forces of population differentiation and positive selection vary among genes involved in the same metabolic pathway but subject to different functional constraints. Results Our results show that genes in the downstream part of the pathway are more likely to show a signature of population differentiation, while events of positive selection are equally distributed among the two parts of the pathway. Moreover, events of positive selection are frequent on genes that are known to be at bifurcation points, and that are identified as being in key position by a network-level analysis such as MGAT3 and GCS1. Conclusions These findings indicate that the upstream part of the Asparagine N-Glycosylation pathway has lower diversity among populations, while the downstream part is freer to tolerate diversity among populations. Moreover, the distribution of signatures of population differentiation and positive selection can change between parts of a pathway, especially between parts that are exposed to different functional constraints. Our results support the hypothesis that genes involved in constitutive processes can be expected to show lower population differentiation, while genes involved in traits related to the environment should show higher variability. Taken together, this work broadens our knowledge on how events of population differentiation and of positive selection are distributed among different parts of a metabolic pathway. Keywords: Homo sapiens, Positive selection, Population differentiation, Asparagine N-Glycosylation, Glycosylation, Pathway analysis, Calnexin/calreticulin cycle, Adaptation to environment
ArticleNumber 98
Audience Academic
Author Montanucci, Ludovica
Dall’Olio, Giovanni Marco
Luisi, Pierre
Bertranpetit, Jaume
Sikora, Martin
Laayouni, Hafid
AuthorAffiliation 2 Department of Genetics, Stanford University School of Medicine, Stanford, USA
1 IBE, Institut de Biologia Evolutiva (UPF-CSIC), Parc de Recerca Biomèdica de Barcelona (PRBB), Dr. Aiguader, 88, 08003, Barcelona, Catalonia, Spain
AuthorAffiliation_xml – name: 2 Department of Genetics, Stanford University School of Medicine, Stanford, USA
– name: 1 IBE, Institut de Biologia Evolutiva (UPF-CSIC), Parc de Recerca Biomèdica de Barcelona (PRBB), Dr. Aiguader, 88, 08003, Barcelona, Catalonia, Spain
Author_xml – sequence: 1
  givenname: Giovanni Marco
  surname: Dall’Olio
  fullname: Dall’Olio, Giovanni Marco
– sequence: 2
  givenname: Hafid
  surname: Laayouni
  fullname: Laayouni, Hafid
– sequence: 3
  givenname: Pierre
  surname: Luisi
  fullname: Luisi, Pierre
– sequence: 4
  givenname: Martin
  surname: Sikora
  fullname: Sikora, Martin
– sequence: 5
  givenname: Ludovica
  surname: Montanucci
  fullname: Montanucci, Ludovica
– sequence: 6
  givenname: Jaume
  surname: Bertranpetit
  fullname: Bertranpetit, Jaume
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22731960$$D View this record in MEDLINE/PubMed
BookMark eNp1U01v1DAQjVAR_YAzNxSJCxzS2o7jOByQSvlaqQKJj7M1sSdbV9l4sZ3C_gV-Nc5uWe1WrSIrnpn33jjjl-PsYHADZtlzSk4pleKM8poWjHJZUFY08lF2tM0c7OwPs-MQrgmhtWT0SXbIWF3SRpCj7O97G6K37RitG3LX5XiDQwzTbumCjfYG84A96nUdBpPSy7GHdWhs16FPeLuJbULkC4zQut7qfAnx6jes3uTxCnMNASdVCEvwMLcD5l-Keb_SLqw2ck-zxx30AZ_dvk-ynx8__Lj4XFx-_TS7OL8sWiGbWFAgDWOl6IhkQhracZCUUuBomKxKYyRpEWrGiayE5jrVG1FiRXQDojVVeZLNNrrGwbVaersAv1IOrFonnJ8r8NHqHlVbVqbhJW_aGnhbV0BqwwxWvE1qdUWT1tuN1nJsF2h0moWHfk90vzLYKzV3N6rkTHDJkwDdCOgwauVRo9cQ18RtMC1GaqYYLSkpE-fdhtNa90DT_Yp2CzV5QU1eUJSpRiaRV7cn9-7XiCGqhQ0a-x4GdGNQqVGVliBNgr68A712ox_SHU0oLppa1DuoOaTJ2aFzqbeeRNV5VXLSCC6m7z29B5Uegwurk7k7m_J7hNd7hISJ-CfOYQxBzb5_28e-2L2N7UT-2z0Bzm6n7V0IHrsthBI1_VD3jKm6w9A2ru2azm37B3n_ACNAIx8
CitedBy_id crossref_primary_10_1534_g3_117_042671
crossref_primary_10_1093_molbev_msac044
crossref_primary_10_1186_1471_2156_15_76
crossref_primary_10_2217_bmm_2019_0005
crossref_primary_10_1093_gbe_evu270
crossref_primary_10_1155_2016_4658506
crossref_primary_10_1093_gbe_evv055
crossref_primary_10_1098_rspb_2015_2215
crossref_primary_10_1074_jbc_R112_424523
crossref_primary_10_1186_s12864_020_06878_3
crossref_primary_10_1186_s13062_019_0248_7
crossref_primary_10_1093_nar_gkt1188
crossref_primary_10_1111_evo_12548
Cites_doi 10.1101/gr.5157306
10.1126/science.296.5566.261b
10.1093/bioinformatics/btq675
10.1101/gr.087577.108
10.1111/j.1600-0854.2009.00981.x
10.1111/j.1469-1809.2006.00285.x
10.1101/gr.361602
10.1146/annurev.genet.36.050802.093940
10.1086/502802
10.1016/j.sbi.2009.07.002
10.1002/cbic.200400143
10.1002/bit.21062
10.1186/1471-2148-9-206
10.1101/gr.5105206
10.1038/nprot.2007.324
10.1371/journal.pone.0000713
10.1016/j.cell.2006.08.022
10.1093/glycob/cwq215
10.1016/j.gene.2006.06.028
10.1146/annurev.biochem.69.1.69
10.1074/jbc.R700048200
10.1007/s00239-003-2544-0
10.1016/j.cell.2009.12.008
10.1038/ejhg.2009.115
10.1007/s00418-007-0366-7
10.1111/j.1749-6632.2010.05840.x
10.1371/journal.pbio.0040072
10.1093/glycob/cwi063
10.1093/oxfordjournals.molbev.a004208
10.1038/sj.gene.6364266
10.1093/molbev/msq259
10.1158/0008-5472.CAN-09-2719
10.1126/science.1153717
10.1002/humu.21126
10.1016/j.sbi.2009.06.004
10.1111/j.1469-1809.1949.tb02451.x
10.1093/bioinformatics/btp517
10.1038/sj.gene.6364117
10.1073/pnas.0710183104
10.1186/gb-2006-7-5-r39
10.1093/glycob/9.8.747
10.1101/gr.084038.108
ContentType Journal Article
Copyright COPYRIGHT 2012 BioMed Central Ltd.
2012 Dall'Olio et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
(c) 2012 Dall'Olio et al. Creative Commons Attribution License info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.0
Copyright ©2012 Dall'Olio et al.; licensee BioMed Central Ltd. 2012 Dall'Olio et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2012 BioMed Central Ltd.
– notice: 2012 Dall'Olio et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: (c) 2012 Dall'Olio et al. Creative Commons Attribution License info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by/2.0/">http://creativecommons.org/licenses/by/2.0/</a>
– notice: Copyright ©2012 Dall'Olio et al.; licensee BioMed Central Ltd. 2012 Dall'Olio et al.; licensee BioMed Central Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QP
7QR
7SN
7SS
7TK
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PYCSY
RC3
7X8
XX2
5PM
DOA
DOI 10.1186/1471-2148-12-98
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest SciTech Premium Collection Natural Science Collection Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
Recercat
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Agricultural & Environmental Science Collection
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE
MEDLINE - Academic




Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1471-2148
EndPage 98
ExternalDocumentID oai_doaj_org_article_b35d94349b7a4b75a07d2de54b0c9751
PMC3426484
oai_recercat_cat_2072_213103
oai_biomedcentral_com_1471_2148_12_98
2742637221
A534096464
22731960
10_1186_1471_2148_12_98
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States
Spain
GeographicLocations_xml – name: Spain
– name: United States
GroupedDBID ---
0R~
23N
2VQ
2WC
2XV
4.4
53G
5VS
6J9
7X7
7XC
88E
8CJ
8FE
8FH
8FI
8FJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1J
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
IPNFZ
ISR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OVT
P2P
PATMY
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PYCSY
RBZ
RIG
RNS
ROL
RPM
SBL
SV3
TR2
TUS
U2A
UKHRP
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
3V.
7QP
7QR
7SN
7SS
7TK
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
-A0
ADINQ
AFGXO
BMC
C24
C6C
OK1
RSV
SOJ
PUEGO
XX2
5PM
ID FETCH-LOGICAL-b689t-1a092236f08268d1f4a8111a4ed2853dd80bea7240856c4cf4a963e50c9a6bd53
IEDL.DBID RBZ
ISSN 1471-2148
IngestDate Wed Aug 27 01:23:24 EDT 2025
Thu Aug 21 18:17:58 EDT 2025
Fri Aug 29 12:40:14 EDT 2025
Tue Apr 16 22:44:21 EDT 2024
Thu Jul 10 17:43:42 EDT 2025
Fri Jul 25 10:39:36 EDT 2025
Tue Jun 17 22:04:49 EDT 2025
Mon Jul 21 10:57:36 EDT 2025
Fri Jun 27 05:57:27 EDT 2025
Mon Jul 21 06:07:13 EDT 2025
Thu Apr 24 23:08:03 EDT 2025
Tue Jul 01 04:27:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b689t-1a092236f08268d1f4a8111a4ed2853dd80bea7240856c4cf4a963e50c9a6bd53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/1471-2148-12-98
PMID 22731960
PQID 1034697679
PQPubID 44659
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_b35d94349b7a4b75a07d2de54b0c9751
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3426484
csuc_recercat_oai_recercat_cat_2072_213103
biomedcentral_primary_oai_biomedcentral_com_1471_2148_12_98
proquest_miscellaneous_1035103609
proquest_journals_1034697679
gale_infotracmisc_A534096464
gale_infotracacademiconefile_A534096464
gale_incontextgauss_ISR_A534096464
pubmed_primary_22731960
crossref_primary_10_1186_1471_2148_12_98
crossref_citationtrail_10_1186_1471_2148_12_98
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-06-25
PublicationDateYYYYMMDD 2012-06-25
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-25
  day: 25
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC evolutionary biology
PublicationTitleAlternate BMC Evol Biol
PublicationYear 2012
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References H Cann (2043_CR38) 2002; 296
S Wright (2043_CR1) 1951; 15
GM Dall’Olio (2043_CR41) 2011; 21
P Hossler (2043_CR17) 2007; 2
KM Teshima (2043_CR35) 2006; 16
P Hossler (2043_CR16) 2006; 95
JL Kelley (2043_CR43) 2006; 16
I Grossman (2043_CR4) 2004; 5
D Shental-Bechor (2043_CR9) 2009; 19
PM Kim (2043_CR18) 2007; 104
G Scardoni (2043_CR26) 2009; 25
MW Hahn (2043_CR33) 2004; 58
G Peng (2043_CR27) 2009; 18
JZ Li (2043_CR37) 2008; 319
AJ Parodi (2043_CR7) 2000; 69
A Varki (2043_CR21) 2009
GZ Lederkremer (2043_CR8) 2009; 19
JW Dennis (2043_CR19) 2009; 10
P Gagneux (2043_CR24) 1999; 9
A Harduin-Lepers (2043_CR22) 2005; 15
JW Dennis (2043_CR20) 2009; 139
Y Song (2043_CR28) 2010; 70
D Alvarez-Ponce (2043_CR32) 2009; 19
J Jaeken (2043_CR14) 2010; 1214
L Montanucci (2043_CR25) 2011; 28
BS Weir (2043_CR2) 2002; 36
2043_CR44
T Makino (2043_CR29) 2006; 385
A Varki (2043_CR23) 2006; 126
2043_CR49
2043_CR48
2043_CR47
JE Stajich (2043_CR42) 2002; 12
MA Haeuptle (2043_CR13) 2009; 30
ME Smoot (2043_CR46) 2011; 27
JK Pickrell (2043_CR36) 2009; 19
D Vitkup (2043_CR30) 2006; 7
AW Ryan (2043_CR5) 2006; 7
P Luisi (2043_CR34) 2011
YH Yang (2043_CR31) 2009; 9
J Roth (2043_CR10) 2008; 129
R Oriol (2043_CR12) 2002; 19
N Rosenberg (2043_CR39) 2006; 70
MS Cline (2043_CR45) 2007; 2
P Stanley (2043_CR11) 2009
MP Murrell (2043_CR15) 2004; 5
BF Voight (2043_CR3) 2006; 4
P Scheet (2043_CR40) 2006; 78
JJ Caramelo (2043_CR6) 2008; 283
16532393 - Am J Hum Genet. 2006 Apr;78(4):629-44
19689796 - BMC Evol Biol. 2009;9:206
19862844 - Hum Mutat. 2009 Dec;30(12):1628-41
17684559 - PLoS One. 2007;2(8):e713
21149340 - Bioinformatics. 2011 Feb 1;27(3):431-2
22135191 - Mol Biol Evol. 2012 May;29(5):1379-92
15042341 - J Mol Evol. 2004 Feb;58(2):203-11
16494531 - PLoS Biol. 2006 Mar;4(3):e72
15843597 - Glycobiology. 2005 Aug;15(8):805-17
16684370 - Genome Biol. 2006;7(5):R39
19141596 - Genome Res. 2009 Feb;19(2):234-42
16825663 - Genome Res. 2006 Aug;16(8):980-9
18077332 - Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20274-9
12368254 - Genome Res. 2002 Oct;12(10):1611-8
20924085 - Mol Biol Evol. 2011 Jan;28(1):813-23
21175687 - Ann N Y Acad Sci. 2010 Dec;1214:190-8
19729372 - Bioinformatics. 2009 Nov 1;25(21):2857-9
12200473 - Mol Biol Evol. 2002 Sep;19(9):1451-63
16807922 - Biotechnol Bioeng. 2006 Dec 5;95(5):946-60
19307593 - Genome Res. 2009 May;19(5):826-37
19647993 - Curr Opin Struct Biol. 2009 Oct;19(5):524-33
19584899 - Eur J Hum Genet. 2010 Jan;18(1):111-7
16959563 - Cell. 2006 Sep 8;126(5):841-5
16687733 - Genome Res. 2006 Jun;16(6):702-12
20064370 - Cell. 2009 Dec 24;139(7):1229-41
19616933 - Curr Opin Struct Biol. 2009 Oct;19(5):515-23
21199820 - Glycobiology. 2011 Nov;21(11):1395-400
17947979 - Nat Protoc. 2007;2(10):2366-82
15457533 - Chembiochem. 2004 Oct 4;5(10):1334-47
17044859 - Ann Hum Genet. 2006 Nov;70(Pt 6):841-7
16222342 - Genes Immun. 2006 Mar;7(2):179-83
10406840 - Glycobiology. 1999 Aug;9(8):747-55
18303019 - J Biol Chem. 2008 Apr 18;283(16):10221-5
20395209 - Cancer Res. 2010 Apr 15;70(8):3361-71
24540312 - Ann Eugen. 1951 Mar;15(4):323-54
12359738 - Annu Rev Genet. 2002;36:721-50
15269719 - Genes Immun. 2004 Sep;5(6):493-504
11954565 - Science. 2002 Apr 12;296(5566):261-2
18292342 - Science. 2008 Feb 22;319(5866):1100-4
19761541 - Traffic. 2009 Nov;10(11):1569-78
16979849 - Gene. 2006 Dec 30;385:57-63
10966453 - Annu Rev Biochem. 2000;69:69-93
18075753 - Histochem Cell Biol. 2008 Feb;129(2):163-77
References_xml – volume: 16
  start-page: 980
  year: 2006
  ident: 2043_CR43
  publication-title: Genome Res
  doi: 10.1101/gr.5157306
– volume: 296
  start-page: 261
  year: 2002
  ident: 2043_CR38
  publication-title: Science
  doi: 10.1126/science.296.5566.261b
– volume: 27
  start-page: 431
  year: 2011
  ident: 2043_CR46
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq675
– volume: 19
  start-page: 826
  year: 2009
  ident: 2043_CR36
  publication-title: Genome Res
  doi: 10.1101/gr.087577.108
– volume: 10
  start-page: 1569
  year: 2009
  ident: 2043_CR19
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00981.x
– volume: 70
  start-page: 841
  year: 2006
  ident: 2043_CR39
  publication-title: Ann Hum Genet
  doi: 10.1111/j.1469-1809.2006.00285.x
– volume: 12
  start-page: 1611
  year: 2002
  ident: 2043_CR42
  publication-title: Genome Res
  doi: 10.1101/gr.361602
– volume: 36
  start-page: 721
  year: 2002
  ident: 2043_CR2
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev.genet.36.050802.093940
– volume: 78
  start-page: 629
  year: 2006
  ident: 2043_CR40
  publication-title: Am J Hum Genet
  doi: 10.1086/502802
– volume: 19
  start-page: 524
  year: 2009
  ident: 2043_CR9
  publication-title: Curr Opin Struct Biol
  doi: 10.1016/j.sbi.2009.07.002
– volume: 5
  start-page: 1334
  year: 2004
  ident: 2043_CR15
  publication-title: Chembiochem: a European journal of chemical biology
  doi: 10.1002/cbic.200400143
– volume: 95
  start-page: 946
  year: 2006
  ident: 2043_CR16
  publication-title: Biotechnol Bioeng
  doi: 10.1002/bit.21062
– volume-title: Glycans in Acquired Human Diseases
  year: 2009
  ident: 2043_CR21
– volume: 9
  start-page: 206
  year: 2009
  ident: 2043_CR31
  publication-title: BMC Evol Biol
  doi: 10.1186/1471-2148-9-206
– volume: 16
  start-page: 702
  year: 2006
  ident: 2043_CR35
  publication-title: Genome Res
  doi: 10.1101/gr.5105206
– volume: 2
  start-page: 2366
  year: 2007
  ident: 2043_CR45
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.324
– volume-title: Mol Biol Evol
  year: 2011
  ident: 2043_CR34
– volume: 2
  start-page: e713
  issue: 1
  year: 2007
  ident: 2043_CR17
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000713
– volume: 126
  start-page: 841
  year: 2006
  ident: 2043_CR23
  publication-title: Cell
  doi: 10.1016/j.cell.2006.08.022
– ident: 2043_CR48
– volume: 21
  start-page: 1395
  year: 2011
  ident: 2043_CR41
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwq215
– ident: 2043_CR44
– volume: 385
  start-page: 57
  year: 2006
  ident: 2043_CR29
  publication-title: Gene
  doi: 10.1016/j.gene.2006.06.028
– volume: 69
  start-page: 69
  year: 2000
  ident: 2043_CR7
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.69.1.69
– volume: 283
  start-page: 10221
  year: 2008
  ident: 2043_CR6
  publication-title: J Biol Chem
  doi: 10.1074/jbc.R700048200
– volume: 58
  start-page: 203
  year: 2004
  ident: 2043_CR33
  publication-title: J Mol Evol
  doi: 10.1007/s00239-003-2544-0
– volume: 139
  start-page: 1229
  year: 2009
  ident: 2043_CR20
  publication-title: Cell
  doi: 10.1016/j.cell.2009.12.008
– volume: 18
  start-page: 111
  year: 2009
  ident: 2043_CR27
  publication-title: European journal of human genetics: EJHG
  doi: 10.1038/ejhg.2009.115
– volume: 129
  start-page: 163
  year: 2008
  ident: 2043_CR10
  publication-title: Histochem Cell Biol
  doi: 10.1007/s00418-007-0366-7
– volume: 1214
  start-page: 190
  year: 2010
  ident: 2043_CR14
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2010.05840.x
– volume: 4
  start-page: e72
  issue: 3
  year: 2006
  ident: 2043_CR3
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.0040072
– volume: 15
  start-page: 805
  year: 2005
  ident: 2043_CR22
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwi063
– volume: 19
  start-page: 1451
  year: 2002
  ident: 2043_CR12
  publication-title: Mol Biol Evol
  doi: 10.1093/oxfordjournals.molbev.a004208
– ident: 2043_CR47
– volume: 7
  start-page: 179
  year: 2006
  ident: 2043_CR5
  publication-title: Genes Immun
  doi: 10.1038/sj.gene.6364266
– volume-title: N-Glycans
  year: 2009
  ident: 2043_CR11
– volume: 28
  start-page: 813
  year: 2011
  ident: 2043_CR25
  publication-title: Mol Biol Evol
  doi: 10.1093/molbev/msq259
– volume: 70
  start-page: 3361
  year: 2010
  ident: 2043_CR28
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-2719
– volume: 319
  start-page: 1100
  year: 2008
  ident: 2043_CR37
  publication-title: Science
  doi: 10.1126/science.1153717
– ident: 2043_CR49
– volume: 30
  start-page: 1628
  year: 2009
  ident: 2043_CR13
  publication-title: Hum Mutat
  doi: 10.1002/humu.21126
– volume: 19
  start-page: 515
  year: 2009
  ident: 2043_CR8
  publication-title: Curr Opin Struct Biol
  doi: 10.1016/j.sbi.2009.06.004
– volume: 15
  start-page: 323
  year: 1951
  ident: 2043_CR1
  publication-title: Ann Eugen
  doi: 10.1111/j.1469-1809.1949.tb02451.x
– volume: 25
  start-page: 2857
  year: 2009
  ident: 2043_CR26
  publication-title: Bioinformatics (Oxford, England)
  doi: 10.1093/bioinformatics/btp517
– volume: 5
  start-page: 493
  year: 2004
  ident: 2043_CR4
  publication-title: Genes Immun
  doi: 10.1038/sj.gene.6364117
– volume: 104
  start-page: 20274
  year: 2007
  ident: 2043_CR18
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0710183104
– volume: 7
  start-page: R39
  year: 2006
  ident: 2043_CR30
  publication-title: Genome Biol
  doi: 10.1186/gb-2006-7-5-r39
– volume: 9
  start-page: 747
  year: 1999
  ident: 2043_CR24
  publication-title: Glycobiology
  doi: 10.1093/glycob/9.8.747
– volume: 19
  start-page: 234
  year: 2009
  ident: 2043_CR32
  publication-title: Genome Res
  doi: 10.1101/gr.084038.108
– reference: 16979849 - Gene. 2006 Dec 30;385:57-63
– reference: 15042341 - J Mol Evol. 2004 Feb;58(2):203-11
– reference: 19307593 - Genome Res. 2009 May;19(5):826-37
– reference: 21149340 - Bioinformatics. 2011 Feb 1;27(3):431-2
– reference: 15269719 - Genes Immun. 2004 Sep;5(6):493-504
– reference: 18292342 - Science. 2008 Feb 22;319(5866):1100-4
– reference: 20395209 - Cancer Res. 2010 Apr 15;70(8):3361-71
– reference: 11954565 - Science. 2002 Apr 12;296(5566):261-2
– reference: 10406840 - Glycobiology. 1999 Aug;9(8):747-55
– reference: 19689796 - BMC Evol Biol. 2009;9:206
– reference: 22135191 - Mol Biol Evol. 2012 May;29(5):1379-92
– reference: 16687733 - Genome Res. 2006 Jun;16(6):702-12
– reference: 16684370 - Genome Biol. 2006;7(5):R39
– reference: 18303019 - J Biol Chem. 2008 Apr 18;283(16):10221-5
– reference: 20924085 - Mol Biol Evol. 2011 Jan;28(1):813-23
– reference: 21199820 - Glycobiology. 2011 Nov;21(11):1395-400
– reference: 12368254 - Genome Res. 2002 Oct;12(10):1611-8
– reference: 24540312 - Ann Eugen. 1951 Mar;15(4):323-54
– reference: 15457533 - Chembiochem. 2004 Oct 4;5(10):1334-47
– reference: 16222342 - Genes Immun. 2006 Mar;7(2):179-83
– reference: 17044859 - Ann Hum Genet. 2006 Nov;70(Pt 6):841-7
– reference: 19647993 - Curr Opin Struct Biol. 2009 Oct;19(5):524-33
– reference: 18077332 - Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20274-9
– reference: 17947979 - Nat Protoc. 2007;2(10):2366-82
– reference: 12200473 - Mol Biol Evol. 2002 Sep;19(9):1451-63
– reference: 17684559 - PLoS One. 2007;2(8):e713
– reference: 16807922 - Biotechnol Bioeng. 2006 Dec 5;95(5):946-60
– reference: 19729372 - Bioinformatics. 2009 Nov 1;25(21):2857-9
– reference: 16825663 - Genome Res. 2006 Aug;16(8):980-9
– reference: 15843597 - Glycobiology. 2005 Aug;15(8):805-17
– reference: 19141596 - Genome Res. 2009 Feb;19(2):234-42
– reference: 19761541 - Traffic. 2009 Nov;10(11):1569-78
– reference: 10966453 - Annu Rev Biochem. 2000;69:69-93
– reference: 19616933 - Curr Opin Struct Biol. 2009 Oct;19(5):515-23
– reference: 12359738 - Annu Rev Genet. 2002;36:721-50
– reference: 16959563 - Cell. 2006 Sep 8;126(5):841-5
– reference: 16532393 - Am J Hum Genet. 2006 Apr;78(4):629-44
– reference: 21175687 - Ann N Y Acad Sci. 2010 Dec;1214:190-8
– reference: 20064370 - Cell. 2009 Dec 24;139(7):1229-41
– reference: 18075753 - Histochem Cell Biol. 2008 Feb;129(2):163-77
– reference: 19862844 - Hum Mutat. 2009 Dec;30(12):1628-41
– reference: 16494531 - PLoS Biol. 2006 Mar;4(3):e72
– reference: 19584899 - Eur J Hum Genet. 2010 Jan;18(1):111-7
SSID ssj0017821
Score 2.1037252
Snippet Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can be...
Background Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can...
Doc number: 98 Abstract Background: Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes....
BACKGROUND: Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can...
Background: Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic pathway can...
Abstract Background Asparagine N-Glycosylation is one of the most important forms of protein post-translational modification in eukaryotes. This metabolic...
SourceID doaj
pubmedcentral
csuc
biomedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 98
SubjectTerms Adaptation to environment
Analysis
Asparagine
Asparagine - genetics
Asparagine N-Glycosylation
Calnexin/calreticulin cycle
Evolution, Molecular
Genes
Genetic aspects
Genetic Variation
Genetics
Genetics, Population
Genome, Human
Genètica de poblacions humanes
Genètica evolutiva
Glycosylation
Haplotypes
Homo sapiens
Human populations
Humans
Membrane proteins
Metabolic Networks and Pathways
Metabolism
Models, Genetic
Natural selection
Pathway analysis
Physiological aspects
Population differentiation
Positive selection
Post-translational modification
Protein Processing, Post-Translational
Proteins
Selection, Genetic
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA-yIPgifls9JYqgCPXaNElbfTo_jlPwHtSDewv56rmwduXaVfZf8K92Jk3L1kN88WFhNzNpm8xkZrKd_IaQJ9w1eWO4Tqtci5Q3Daw5YVhagLMRjjFdhL-yPx7LoxP-4VSc7pT6wpywAR54mLh9UwiHGGa1KTU3pdBZ6ZjzgpvM1mU4PM3A542bqfj-APxe2GqB6U0ZRPwR1Cev5P7UhkkJdfXHQffVzD8tbLexEc3_os3ecVrzhModD3V4jVyNoSU9GIZ0nVzy7Q1yeSg2ub1Jfr1FjNxY3oquGxqwmzr8NmRu_fC0C1VxkK5bB81jcS861lHpB0nSJXDQb74HFVotLcW6xj_19iWFcJJacIx4Vd0hrjjCHdLj9Gy1tetuO1zuFjk5fPflzVEaKzGkRlZ1n-Y6qyGOkA0EDLJyecN1BUZSc-8Y-Hvnqsx4XQa4NGm5BTosbC9ARFoaJ4rbZNGuW3-XUOkbjm_-vXENb7SrZZlpqXnppTAQuyTk1Uwe6vuAuqEQB3tOgSWpUJoKpalypuoqIS9G6SkbQc6x1sZKhc1OJS92eDZ1GO_0V9bnqA4KPJE_t7oPTzT9wA_LSgYdsHRbQl6j0syePjSAbquo2-pfup2Qx6hyCnE6WkwEOtObrlPvP39SB6KAnbnkkifkaWRq1jBUq-O5CphuhPaace7NOMGQ2Dl51GwVDVkHc1FwCSFrWSfk0UTGnpic1_r1JvAgLqPMgOfOsBCmcTMIj8HIg1jL2RKZTcyc0i6_BpjzAoP1it_7HzN5n1wB48Mwx4-JPbLozzf-AUSTvXkYDMdv4k9wpw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9NAFB60Ivgi3o2uEkVQhGgymUuiD7JellVwH9SFvg1zSy3UZG1SpX_BX-05yaRuXPSh0OacSSc515mcfIeQR8xVWWWYTopM84RVFdgcNzTJIdhwR6nO-63sj0fi8Jh9mPN52HBrQ1nl6BN7R-0ai3vkYN05rOSkkOWrk-8Jdo3Cp6uhhcZ5cgGhy7CkS853C64Mol8W4HyyQjzPwBEnFHfQMpqUxV-vuK8mkWlm240NOP5nvfWpcDUtpTwVmw6ukMshqYz3By24Ss75-hq5OLSZ3F4nv94iOm5obBU3VdyjNrX4bajZ-uHjtu-Hg3RdOzg8tvWKxw4q3SDDeAkc8TffgfKsljbGjsY_9fZFDIlkbCEk4ll1i4jiCHQYHyWL1dY27XY43Q1yfPDuy5vDJPRgSIwoyi7JdFpCBiEqSBVE4bKK6QLco2beUYj0zhWp8Vr2QGnCMgt0MGnPU1tqYRzPb5JZ3dT-NomFrxg-8_fGVazSrhQy1UIz6QU3kLVE5OVEHupkwNtQiIA9pYBiKJSmQmmqjKqyiMizUXrKBnhz7LKxUv0ypxBnBzzZDRj_6Z-sT1EdFMQgv7a662e0-4EfmkoKA7BpW0Reo9JMZt8faNYLFdyBMjl3iMxXGqmZkVyn0lHnOTNw4yTPIvIQVU4hQkeNJUALvWlb9f7zJ7XPc1iTCyZYRB4HpqqBS7U6vFEBtxtBvSacexNOcCF2Sh41WwUX1qo_BheRBzsyjsSyvNo3m54HERlFCjy3BkPYXTeFxBjcO4hVTkxkcmOmlHr5tQc4zzFNL9id_0_rLrkEDoVi3R7le2TWrTf-HmSInbnfu4Hfkc9mrg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELegCIkXxDeBgQxCAiFlJI7tJCCExsc0kLYHYNLeLH-lVCoJNC3Qf4G_mjsn6RY2Hnio1ObOTnLn-3B6-R0hj7ir0spwHRepFjGvKrA5YVicQbARjjGdhUfZ-wdy75B_OBJHx-2AegG2Z27tsJ_U4WK-_ev7-hUY_Mtg8IV8loKDjRk-GUtZXBbnyQUISzla6T4__ksBQmHYfQ3MPc7PGRP89e77fBSyJrZd2R7g_7QbPxHHxjWWJ4LW7hVyuc826U63PK6Sc76-Ri52_SfX18nvtwib23e8ok1FA5xTi9-6Yq4fnrahUQ7Sde3g8NDviw6tVZadcukMOOhXv4RVNZ9Ziq2Of-r1cwoZJrUQK3FW3SLUOCIg0oN4Ol_bpl13090gh7vvPr_Zi_vmDLGRRbmMU52UkFrICnIIWbi04roAv6m5dwxSAOeKxHidBwQ1abkFOti6F4kttTROZDfJpG5qf5tQ6SuOxQDeuIpX2pUyT7TUPPdSGEhnIvJipA_1rQPiUAiNPaaAlSrUpkJtqpSpsojI9qA9ZXvcc2y_MVdh_1PI0wOebAYMZ_on61NcDgqCk19YvQxXtPmBH5bkDAZgN7eIvMZFM7r6cKBZTFXvJ5TJhEPIvtLkmptc6CR3zHnBDQguF2lEHuKSUwjdUWNt0FSv2la9__RR7YgMNuuSSx6Rxz1T1cCtWt2_agHiRrSvEefWiBN8ix2Th5WtBtMEWWRcQhablxF5sCHjSKzXq32zCjwI1SgT4LnVGcLmvhlkzOD3Qa35yERGghlT6tmXgHyeYf5e8Dv_I_a75BL4HYblfUxskclysfL3IJFcmvvBQfwB0gRv-w
  priority: 102
  providerName: Scholars Portal
Title Distribution of events of positive selection and population differentiation in a metabolic pathway: the case of asparagine N-glycosylation
URI https://www.ncbi.nlm.nih.gov/pubmed/22731960
https://www.proquest.com/docview/1034697679
https://www.proquest.com/docview/1035103609
http://dx.doi.org/10.1186/1471-2148-12-98
https://recercat.cat/handle/2072/213103
https://pubmed.ncbi.nlm.nih.gov/PMC3426484
https://doaj.org/article/b35d94349b7a4b75a07d2de54b0c9751
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEF_sFcEX8dtoPVYRFCGabPYj0aeetlShh1QLxZdlv1IPzpw0OeX-Bf9qZ5Lc2bT65MOFS2Z2k-zMzsx-5DeEPOW-TEvLTZynRsS8LKHPCcviDJyN8IyZrJ3KPpzKg2P-4USc_AGLvrCCn-byVQrmM2Y475WyuMi3yDbj4AZxYD75slkwAEfXjq3WzD2Kz18quPBl-3zgkEauXroevv-ykT7npYY7KM-5pP0b5HofS9LdTvg3yZVQ3SJXu-ySq9vk1zsExe3zWdFFSVuwphr_dVu1fgRat2lwkG4qD5fX2bzoOnFK04mOzoCDfgsN6Mx85igmMv5pVq8pxI_UgSfEWk2NQOKIb0in8el85Rb1qqvuDjne3_v89iDuUy_EVuZFE6cmKSBwkCVECDL3aclNDlbR8OAZOHjv88QGo1p8NOm4Azr05CASVxhpvcjuklG1qMJ9QmUoOS71B-tLXhpfSJUYabgKUlgIViLyZiAP_b2D2dAIfD2kQB_UKE2N0tQp00UekZdr6WnXo5pjco25bkc3ubxc4PmmwPpO_2R9geqgwfWEM2ea9ok2J_hjiWJQAHO1RWSCSjN4-vYC6LLurYC2mfAIyFdYZbhVwiTKMx8Et9BwSqQReYIqpxGYo8KdP6dmWdf6_acjvSsyGIpLLnlEnvVM5QJe1Zn-QwpobsTyGnDuDDjBcrghea3ZurdcNbRFxiXEqKqIyOMNGUvibrwqLJYtDwIxygR47nUdYfPeDOJhsOogVjXoIoOGGVKq2dcW1zzD6DznD_5LIR6Sa2BmGO7mY2KHjJqzZXgEcWNjx2RLnagx2Z7sTT8ejdvZFzge8nzc2pLfuShthQ
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELamTgi-IN4JDDAIBEIKJI7jJCCENrapY1uFxibtm3Fsp1QqyWhSpv4Ffgy_kbu8lIUJvu1DpTY-p47vfGc75-ch5Ck3mZ-lXLmxr0KXZxmMuTBlbgDBJjSMqaDeyt4fieER_3gcHq-QX91ZGEyr7Hxi7ahNoXGPHEZ3ACu5SETJ-5PvLrJG4dvVjkKjMYtduziFJVv5bmcT9PuMse2tww9Dt2UVcFMRJ5XrKy-BmCgyCH4iNn7GVQwDXnFrGMQuY2IvtSqqob-E5hrKwUht6OlEidQgSwS4_FUewFJmQFY3tkafDpbvLSDe-i2AkB-L1z64fpfhnp3P3CT-61D9tBcLB7qc65Y54Hx8OBMg-8mbZ6Lh9jVytZ3G0vXG7q6TFZvfIJcaYsvFTfJzE_F4WyotWmS0xokq8VuTJfbD0rJm4MFylRu43BGJ0Y6zpWqshk5Agn6zFZjrdKIpciifqsUbClNXqiEI411ViRjmCK1IR-54utBFuWhud4scXYh-bpNBXuT2LqHCZhyzDGxqMp4pk4jIU0LxyIowhXmSQ9729CFPGoQPiZjb_RIwRYnalKhN6TOZxA551WlP6hZQHXk9prJeWMXifIUXywrdP_1T9CWag4SoZ2daVXWLlj_ww7yIQQWkiXPIBhpNr_X1hWI2lq0DkmkQGsQCTNJI8TQKlRcZZmzIU-i4KPQd8gRNTiImSI5JR2M1L0u58_lArocBh5UuF9whz1uhrIBH1ao9wwHdjTBiPcm1niQ4Ld0v7ixbtk6zlH-GuEMeL4uxJiYC5raY1zKIASk8kLnTDITlczOYikNAAbVGvSHS65h-ST75WkOqB7gwiPm9_zfrEbk8PNzfk3s7o9375Aq4M4ZZgyxcI4NqNrcPYH5apQ9bp0DJl4v2Q78BKm2j7Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9NAEF6VIBAviBtDAYOQQEhu7fXu2oanlhK1HBEKVKp4We3lEJHaVZwU5S_wq5nxEcUUnniI5Hhm187OaWf2G0KeM5tHuWYqSCPFA5bnYHNc0yCGYMMtpSquX2V_GonDY_b-hJ9skXG3F0afGnfeLrqar1okop3Nveiz2oHDgfmxe2bzxu5TsRuBnw0oviCLaJCll8jlhPMEjXW8_239zwJExPohrGNu4X7-MsEfW-Bnvcg1MNXStDj_F735Rjjrl1puxK7hDXK9TTr9vUZLbpItV9wiV5o2lKvb5NcBoue2ja_8MvdrVKcKj5qarnPnV3W_HKSrwsLpru2X33VYWTQy9qfA4Z-6BSjXbGp87Hj8U61e-5Bo-gZCJs6qKkQcRyBEfxRMZitTVqtmujvkePju69vDoO3REGiRZosgUmEGGYbIIZUQqY1yplJwn4o5SyETsDYNtVNJDaQmDDNAB5N3PDSZEtry-C4ZFGXh7hNfuJxhTYDTNme5splIQiUUS5zgGrIaj7zpyUOeNXgcEhGy-xRQEInSlChNGVGZpR7Z6aQnTQt_jl04ZrJ-DErFxQEv1wO6K_2T9RWqg4QY5eZGLeo7Wn_BDw0TCgOwqZtH9lFpendfnyjnE9m6C6ljbhG5L9OJYjrhKkwstY4zDQuX8Mgjz1DlJCJ4FFgiNFHLqpJHX8Zyj8fwzC6YYB550TLlJZqLandcwHIj6FePc7vHCS7G9MmdZsvWxVWwFjETkMwmmUeersk4Esv2Clcuax5EbBQh8NxrDGH9uykkzuD-QaxJz0R6C9OnFNPvNQB6jGl8yh78l0I8IVc_Hwzlx6PRh4fkGrgmihWAlG-TwWK-dI8g11zox7Xz-A3sH3yj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+of+events+of+positive+selection+and+population+differentiation+in+a+metabolic+pathway%3A+the+case+of+asparagine+N-glycosylation&rft.jtitle=BMC+evolutionary+biology&rft.au=Dall%27Olio%2C+Giovanni+Marco&rft.au=Laayouni%2C+Hafid&rft.au=Luisi%2C+Pierre&rft.au=Sikora%2C+Martin&rft.date=2012-06-25&rft.pub=BioMed+Central&rft.issn=1471-2148&rft.eissn=1471-2148&rft_id=info:doi/10.1186%2F1471-2148-12-98&rft.externalDocID=oai_recercat_cat_2072_213103
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2148&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2148&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2148&client=summon